| Gene Symbol | SLC16A2 |
| Full Name | Monocarboxylate transporter 8 |
| Protein Family | transporter |
| Target Class | Transporter |
| Mechanism of Action | Substrate supplementation or transporter modulation |
| Druggability | Low (0.39) |
| Clinical Stage | Phase I |
| Pathways | X chromosome, SLC16 family, thyroid function, Blood-Brain Barrier, Lactate/monocarboxylate transport |
| GeneCards | SLC16A2 |
| Human Protein Atlas | SLC16A2 |
| Associated Diseases | Aging, ALI, Allan-Herndon-Dudley syndrome, Als, AMI |
| Known Drugs/Compounds | Triiodothyroacetic acid |
| Interactions | C1Q, CANCER, CYP2E1, GSS, JUN, MCT8 |
| SciDEX Target | View Target Profile (1 clinical trials) |
| SciDEX Hypotheses | Astrocytic Lactate Shuttle Enhancement for Grid Ce |
| KG Connections | 158 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!
No comments yet. Be the first to comment!